NCT04420975 2026-03-10
Nivolumab and BO-112 Before Surgery for the Treatment of Resectable Soft Tissue Sarcoma
Jonsson Comprehensive Cancer Center
Phase 1 Active not recruiting
Clinical Trials
6 trialsNCT06422936 2026-01-26
SPOTLIGHT204
Highlight Therapeutics
Phase 2 Active not recruiting
NCT04570332 2025-11-26
SPOTLIGHT203
Highlight Therapeutics
Phase 2 Completed
NCT04508140 2024-11-29
Study of BO-112 With Pembrolizumab for Colorectal or Gastric/GEJ Cancer With Liver Metastasis
Highlight Therapeutics
Phase 2 Terminated
NCT04777708 2023-03-24
BO-112 and Pembrolizumab for the Treatment of PD-1/PD-L1 Refractory Liver Cancer
Jonsson Comprehensive Cancer Center
Phase EARLY_PHASE1 Terminated
NCT05265650 2022-07-19
Noelia
Clinica Universidad de Navarra, Universidad de Navarra
Phase 1/2 Unknown